Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1Diabetes Mellitus, Type 2 1Diabetes Mellitus 1

Interventions

relacorilant 5Resistance Training 3Pioglitazone 2Nutritional Status 2Metformin 2saxagliptin 1pembrolizumab 1mazdutide 1dapagliflozin 1Sitagliptin Phosphate 1Resistant Starch 1Plant Proteins 1Nutrition Assessment 1Methods 1Insulin Lispro 1Insulin Glargine 1Exercise Movement Techniques 1Exercise 1Ethanol 1Endodontics 1Educational Status 1Early Intervention, Educational 1Diet 1Continuous Glucose Monitoring 1Circuit-Based Exercise 1Cholecalciferol 1Blood Specimen Collection 1Ascorbic Acid 1ASP3662 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Diabetes Mellitus, Type 2 × saxagliptin × Clear all
NCT07033585 2025-07-11

GD-T2D

Medicine Invention Design, Inc

Phase 2/3 Active not recruiting
600 enrolled

Diabetes Mellitus, Diabetes Mellitus, Type 2

Data powered by HemOnc (CC BY 4.0) Colophon âš¡